Artificial intelligence (AI) can detect fat around the heart which is invisible to the human eye and predict a person’s risk of heart failure five years before it develops, according to a new study.

Paula Vanderpluym's smartwatch may look like a small part of her wardrobe, but to a team of researchers in Toronto, it ...

EBR Systems, Inc., developer of the world’s only leadless left ventricular endocardial pacing (LVEP) system for heart failure, today announced its participation in the Heart Rhythm 2026 conference, ...

By early detection of fluid in the lungs, a device allows early therapy adjustments to reduce all-cause mortality in patients ...

Stable patients who stop taking beta-blockers a year or more after a heart attack fare no worse than those who keep taking ...

Researchers from the University of Oxford have developed an innovative new AI tool that examines routine heart CT scans ...

Morgans healthcare analyst Iain Wilkie highlights seven ASX companies with upcoming catalysts in 2026 for investors to watch.

A new AI tool from the University of Oxford has an accuracy rate of 86 per cent with doctors hailing it as a ‘big step ...

Low-income patients receiving a debit card spent most of the money on things upstream of medical care like food and utilities ...

Mesoblast Limited is upgraded to Buy as Ryoncil outperforms in pediatric SR-aGVHD and advances rapidly into DMD trial. Read ...

The Community Voice is the leading, most-trusted voice of Kansas' African-American community, and has extended its reach to ...

Mesoblast has outlined plans to double initial revenues and develop stem cell drugs for lower back pain, heart failure and ...